最高の Oncology Information Group ポッドキャスト (2025)

1
Dr. Denis Landaverde - Nueva Evidencia del uso de Inibidores de CDK 416 en Cancer Metastatico RH + HER2 - (Spanish) 1:23

8y ago1:23

1:23

Dr. Denis Landaverde - Nueva Evidencia del uso de Inibidores de CDK 416 en Cancer Metastatico RH + HER2 - (Spanish)

1
Dr. Glauber Leitão - Highlights From Day 1 (Portuguese) 1:28

8y ago1:28

1:28

Dr. Glauber Leitão - Highlights From Day 1 (Portuguese)

1
Dr. Darley de Lima Ferreira Filho - Cirurgia Day 1 (Portuguese) 2:00

8y ago2:00

2:00

Dr. Darley de Lima Ferreira Filho - Cirurgia Day 1 (Portuguese

1
Dr. Felipe Zerwes - Cirurgia Day 2 (Portuguese) 2:43

8y ago2:43

2:43

Dr. Felipe Zerwes - Cirurgia Day 2

1
Dr. Carlos Barrios - Highlights from Day 2 (Portuguese) 4:46

8y ago4:46

4:46

Dr. Carlos Barrios - Highlights from Day 2

1
Dr. Gilberto Amorim - Hot Topics em Câncer de Mama (Portuguese) 6:26

8y ago6:26

6:26

Dr. Gilberto Amorim - Hot Topics em Câncer de Mama (Portuguese)

1
Dr. Paulo Lages - Overview in Prostate Cancer 2:44

9y ago2:44

2:44

Dr. Paulo Lages - Overview in Prostate Cancer

1
Dr. Luiz Bruno - Highlights from Day 1 4:41

9y ago4:41

4:41

Dr. Luiz Bruno - Highlights from Day 1

1
Dr. Fabio Schutz - Highlights in Renal Cell Carcinoma 3:19

9y ago3:19

3:19

Dr. Fabio Schutz - Highlights in Renal Cell Carcinoma

1
Dr. Daniel Herchenhorn - Poster Sessions Highlights 6:50

9y ago6:50

6:50

Dr. Daniel Herchenhorn - Poster Sessions Highlights

1
Igor Stukalin - Fourth-line targeted therapy in MRCC 2:25

9y ago2:25

2:25

Igor Stukalin - Fourth-line targeted therapy in MRCC

1
Dr. Toni Choueri - Update in Kidney Cancer 3:21

9y ago3:21

3:21

Dr. Toni Choueri - Update in Kidney Cancer

1
Dr. Steven Yip - Immuno-oncology Agents in MRCC 2:31

9y ago2:31

2:31

Dr. Steven Yip - Immuno-oncology Agents in MRCC

1
Dr. Eric Jonasch - Alternate Sunitinib Schedule 1:15

9y ago1:15

1:15

Dr. Eric Jonasch - Alternate Sunitinib Schedule

1
Dr. Daniel Heng - Renal Cell Carcinoma Updates 3:48

9y ago3:48

3:48

Dr. Daniel Heng - Renal Cell Carcinoma Updates

1
Dr. Daniel George - UPWARD Study 3:39

9y ago3:39

3:39

Dr. Daniel George - UPWARD Study

聞く価値のあるポッドキャスト

ポッドキャスト Oncology Information Group

聞く価値のあるポッドキャスト

1
Oncology Information Group Podcast

Oncology Information Group

1
Dr. Denis Landaverde - Nueva Evidencia del uso de Inibidores de CDK 416 en Cancer Metastatico RH + HER2 - (Spanish) 1:23

1
Dr. Glauber Leitão - Highlights From Day 1 (Portuguese) 1:28

1
Dr. Darley de Lima Ferreira Filho - Cirurgia Day 1 (Portuguese) 2:00

1
Dr. Felipe Zerwes - Cirurgia Day 2 (Portuguese) 2:43

1
Dr. Carlos Barrios - Highlights from Day 2 (Portuguese) 4:46

1
Dr. Gilberto Amorim - Hot Topics em Câncer de Mama (Portuguese) 6:26

1
Dr. Paulo Lages - Overview in Prostate Cancer 2:44

1
Dr. Luiz Bruno - Highlights from Day 1 4:41

1
Dr. Fabio Schutz - Highlights in Renal Cell Carcinoma 3:19

1
Dr. Daniel Herchenhorn - Poster Sessions Highlights 6:50

1
Igor Stukalin - Fourth-line targeted therapy in MRCC 2:25

1
Dr. Toni Choueri - Update in Kidney Cancer 3:21

1
Dr. Steven Yip - Immuno-oncology Agents in MRCC 2:31

1
Dr. Eric Jonasch - Alternate Sunitinib Schedule 1:15

1
Dr. Daniel Heng - Renal Cell Carcinoma Updates 3:48

1
Dr. Daniel George - UPWARD Study 3:39

クイックリファレンスガイド